Abstract
The purpose of this study was to determine the maximum daily patient-reported pain scores for those patients who experienced subarachnoid hemorrhage (SAH) and to assess how medications were used. A retrospective review of the electronic records of patients who experienced SAH was performed to evaluate patient demographics and comorbidities. The daily pain scores were statistically significant on day 5. Morphine equivalent dosing for day 1 admissions was as follows: patients with a Hunt and Hess (HH) score of I = 2.69, II = 5.52, and III = 0.86 (P = .009). Patients with SAH with an HH score of I and II had similar headaches but received more acetaminophen than patients with an HH score of III.AU
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
